VectivBio is a startup based in Switzerland, most recent round Acquired, 2 tracked investors.
VectivBio is a startup founded in 2017 based in Switzerland. VectivBio has been acquired. Brouky records 2 investors associated with the company.
VectivBio was a clinical-stage biopharmaceutical company focused on developing innovative treatments for severe rare conditions, notably apraglutide for short bowel syndrome.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.